Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 01.06.2026 1 Acta Biochim Biophys Sin (Shanghai) 1 Adv Protein Chem Struct Biol 1 Adv Radiat Oncol 1 Adv Sci (Weinh) 1 Antibodies (Basel) 1 Biochem Biophys Res Commun 1 Biomed Phys Eng Express 1 BJOG 2 BMC Cancer 1 BMC Infect Dis 1 BMC Med Imaging 1 BMC Prim Care 1 BMC Psychiatry 2 BMC Womens Health 2 BMJ Case Rep 1 Br J Radiol 1 Brachytherapy 2 Cancer Genet 1 Cancer Immunol Immunother 1 Cancer Med 3 Cancer Treat Res Commun 1 Cancers (Basel) 1 Cell Death Dis 1 Clin Epigenetics 1 Cureus 1 Curr Oncol 1 Diagn Microbiol Infect Dis 2 Discov Oncol 1 Front Digit Health 2 Front Immunol 2 Front Med (Lausanne) 2 Front Oncol 1 Gynecol Pelvic Med 1 Healthcare (Basel) 1 Hum Cell 1 Hum Vaccin Immunother 1 Immunotherapy 1 Infect Agent Cancer 1 Int J Biol Macromol 1 Int J Environ Res Public Health 1 Int J Gynaecol Obstet 1 Int J Gynecol Cancer 3 Int J Mol Sci 1 Int J Radiat Oncol Biol Phys 1 Int J Womens Health 1 Integr Biol (Camb) 1 J Biomater Sci Polym Ed 1 J Biophotonics 6 J Gynecol Oncol 1 J Health Popul Nutr 3 J Med Screen 1 J Minim Invasive Gynecol 1 J Virol 1 Lasers Med Sci 1 Oncol Rev 2 Pathogens 1 PeerJ 1 Pharmaceuticals (Basel) 1 Pharmacoecon Open 1 Radiother Oncol 1 Sci Rep 1 Stud Health Technol Inform 4 Transl Cancer Res 1 Trop Doct 1 Ultrasound Obstet Gynecol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Biochim Biophys Sin (Shanghai)

1. XIE Z, Di L, He X, Huang M, et al
   DNAJC9 promotes cervical cancer cell proliferation by regulating GLI1 expression.
   Acta Biochim Biophys Sin (Shanghai). 2026;58.
   PubMed         Abstract available
   
   

   
   Adv Protein Chem Struct Biol

2. LOGANATHAN T, Madhulekha S, Zayed H, C GPD, et al
   Identification of common hub genes and pathways in systemic lupus erythematosus and cervical cancer using bioinformatics approach.
   Adv Protein Chem Struct Biol. 2026;152:103-121.
   PubMed         Abstract available
   
   

   
   Adv Radiat Oncol

3. LEE SS, Weil CR, Boyd L, Burt LM, et al
   Trends in Intensity Modulated Radiation Therapy Utilization for Definitive Treatment of Intact Cervical Cancer, 2004-2019.
   Adv Radiat Oncol. 2026;11:102043.
   PubMed         Abstract available
   
   

   
   Adv Sci (Weinh)

4. ZHANG C, Meng Q, Jiao H, Liu H, et al
   HNRNPU K181 Lactylation Drives Cervical Cancer Growth by Upregulating PHGDH and Reprogramming Serine Metabolism.
   Adv Sci (Weinh). 2026 May 27:e20222. doi: 10.1002/advs.202520222.
   PubMed         Abstract available
   
   

   
   Antibodies (Basel)

5. LUPKOWSKI R, Gorniak K, Lisik-Habib M, Burchardt E, et al
   Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.
   Antibodies (Basel). 2026;15:42.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

6. ZHOU Q, Du H, Gao Y, Zhang Q, et al
   Baicalin induces ferroptosis in cervical squamous cell carcinoma via the NRF2/SLC7A11/GPX4 signaling axis.
   Biochem Biophys Res Commun. 2026;822:153876.
   PubMed         Abstract available
   
   

   
   Biomed Phys Eng Express

7. PAFENG J, Celaya A, Gay S, Fuentes D, et al
   RADIANT: A fully configurable radiotherapy dose prediction framework.
   Biomed Phys Eng Express. 2026;12.
   PubMed         Abstract available
   
   

   
   BJOG

8. AGGARWAL A, Rolland P, Leung E, Morrison J, et al
   Sentinel Lymph Node Sampling in Early-Stage Cervical Cancer: A Cross-Sectional Survey.
   BJOG. 2026 May 22. doi: 10.1111/1471-0528.70268.
   PubMed        
   
   

   
   BMC Cancer

9. HE Y, Yang H, Zhang C, Jiang R, et al
   Identification and validation of CNTNAP2/PAX1 hypermethylation as an epigenetic biomarker panel for detection of cervical cancer and precancerous lesions in hrHPV-positive women.
   BMC Cancer. 2026 May 22. doi: 10.1186/s12885-026-16208.
   PubMed         Abstract available
   
   
10. DUDUYEMI BM, Mensah BNO, Addae EK, Sallah L, et al
    Expression of p16 and p53 proteins in cervical cancer cases in a tertiary centre in Ghana: an immunohistochemical study.
    BMC Cancer. 2026 May 27. doi: 10.1186/s12885-026-16266.
    PubMed         Abstract available
    
    

    
    BMC Infect Dis

11. WU J, Yi J, Fang L, Lei S, et al
    Urban-rural disparities in HPV prevalence and genotype distribution: a large-scale cervical cancer screening study in Xi'an, China.
    BMC Infect Dis. 2026 May 28. doi: 10.1186/s12879-026-13647.
    PubMed         Abstract available
    
    

    
    BMC Med Imaging

12. SUN C, Chu A, Liu S, Song R, et al
    Prediction of myelosuppression in cervical cancer after concurrent chemoradiotherapy by CT radiomics-based model.
    BMC Med Imaging. 2026 May 26. doi: 10.1186/s12880-026-02435.
    PubMed         Abstract available
    
    

    
    BMC Prim Care

13. TSUI J, Garcia S, Shin MB, Lui K, et al
    Building capacity for equitable cervical cancer screening and follow-up in an FQHC-NCI cancer center partnership: a mixed-methods study of multilevel implementation determinants.
    BMC Prim Care. 2026 May 22. doi: 10.1186/s12875-026-03387.
    PubMed         Abstract available
    
    

    
    BMC Psychiatry

14. TESHALE MM, Kebede WM, Sahilu WT, Wondimu KS, et al
    Depression among women with cervical cancer: a systematic review and meta-analysis of available evidence.
    BMC Psychiatry. 2026 May 29. doi: 10.1186/s12888-026-08211.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

15. WANG H, Zhu Y, Zhang B, Ding H, et al
    Promoting cervical cancer screening participation among Chinese women from resource-limited settings: a multicenter qualitative study.
    BMC Womens Health. 2026 May 27. doi: 10.1186/s12905-026-04546.
    PubMed         Abstract available
    
    
16. ACAR U, Barlas F, Beyazgul B, Koruk I, et al
    Health belief model-based determinants of women's participation in cervical cancer screening: a case-control study from Southeastern Turkey.
    BMC Womens Health. 2026 May 30. doi: 10.1186/s12905-026-04582.
    PubMed         Abstract available
    
    

    
    BMJ Case Rep

17. ABOELNASR LS, Patel J, Thomson AR, Yazbek J, et al
    Concurrent uterine and pelvic angiolipoleiomyomas.
    BMJ Case Rep. 2026;19:e270120.
    PubMed         Abstract available
    
    
18. MOORTHY S, Raj EH, Sundersingh S, Raja A, et al
    Radiation-induced Osteosarcoma of the vaginal vault following cervical cancer treatment.
    BMJ Case Rep. 2026;19:e269768.
    PubMed         Abstract available
    
    

    
    Br J Radiol

19. SHINDE P, Ak A, Agarwal P, Kamalnath J, et al
    Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy-results from preclinical in-silico dose comparison and quality assurance.
    Br J Radiol. 2026 May 21:tqag075. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Brachytherapy

20. WANG J, Tu Y, Chen Y, Luo L, et al
    Cumulative dose assessment in combined radiotherapy for locally advanced cervical cancer using deformable image registration framework based on BTV dose uniformity.
    Brachytherapy. 2026 May 27:S1538-4721(26)00070.
    PubMed         Abstract available
    
    

    
    Cancer Genet

21. JIA Z, Zhang J, Liu X, Liu C, et al
    ISG15 drives cervical cancer progression by hyperactivating the NOD-like receptor signaling pathway.
    Cancer Genet. 2026;306-307:1-6.
    PubMed         Abstract available
    
    
22. LING HJ, Zhou JL, Cao LQ, Li R, et al
    TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process.
    Cancer Genet. 2026;306-307:34-48.
    PubMed         Abstract available
    
    

    
    Cancer Immunol Immunother

23. CHEN Q, Lyu J, Li Y, Zhang L, et al
    Spatial transcriptomics of cervical cancer reveals microenvironment shaped the malignant epithelial programs and ECM-associated immune niches.
    Cancer Immunol Immunother. 2026 May 29. doi: 10.1007/s00262-026-04439.
    PubMed         Abstract available
    
    

    
    Cancer Med

24. BUSAYO SE, Adewale FL, Ogundokun RO, Adewale OF, et al
    Knowledge and Perception of Cervical Cancer and Pap-Smear Screening Among Antenatal Women in Ogun State, Nigeria.
    Cancer Med. 2026;15:e71949.
    PubMed         Abstract available
    
    

    
    Cancer Treat Res Commun

25. WILKINS K, David O, Oguntoyinbo JO, Zainab H, et al
    Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHS.
    Cancer Treat Res Commun. 2026;48:101256.
    PubMed         Abstract available
    
    
26. LAL S, Pradhan A, Sherpa ML
    "HPV 16/18 E6 DNA and mRNA expression in gross cervical lesions: A hospital based cross-sectional study from Sikkim, India".
    Cancer Treat Res Commun. 2026;47:101209.
    PubMed         Abstract available
    
    
27. WANG X, Xu J, Zhang H, Qu P, et al
    Integrating the Silva pattern into clinical practice: a prognostic tool for tailoring surgery and adjuvant therapy in cervical adenocarcinoma.
    Cancer Treat Res Commun. 2026;47:101187.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

28. GARCIA-BERNAL JR, Resendiz-Castillo LJ, Martinez-Barajas MG, Diaz-Palomera CD, et al
    Differential Protumoral Mechanisms Induced by CAFs in Cervical Cancer Cells Occur Independently of 17beta-Estradiol Stimulation.
    Cancers (Basel). 2026;18:1509.
    PubMed         Abstract available
    
    

    
    Cell Death Dis

29. CHEN L, Lin W, Huang Y, Li C, et al
    Spatiotemporal mapping of CD112 unveils its dichotomous role in T-cell exhaustion and ferroptosis crosstalk in cervical cancer.
    Cell Death Dis. 2026 May 27. doi: 10.1038/s41419-026-08902.
    PubMed         Abstract available
    
    

    
    Clin Epigenetics

30. DE WAARD J, Bhattacharya A, de Boer MT, van Hemel BM, et al
    Clinical validation of a three-marker methylation panel to detect CIN3+ in vaginal self-samples in the Dutch population-based screening programme.
    Clin Epigenetics. 2025;18:97.
    PubMed         Abstract available
    
    

    
    Cureus

31. GOULIARIS M, Papalaskari A, Katsapanteras P, Zoglopitou L, et al
    Cervical Cancer Brachytherapy Dose Escalation Protocol: Analysis of Early Data Treatments According to EMBRACE II Protocol.
    Cureus. 2026;18:e107803.
    PubMed         Abstract available
    
    

    
    Curr Oncol

32. SUSILADEWI IAMV, Afiyanti Y, Allenidekania A, Fitch M, et al
    Perceptions and Behaviors of Healthcare Providers Regarding Sexuality in Cervical Cancer Care: A Qualitative Study.
    Curr Oncol. 2026;33:253.
    PubMed         Abstract available
    
    

    
    Diagn Microbiol Infect Dis

33. SARRIA H, Bernal G
    Prevalence of human papillomavirus in the public health system of the central-northern region of Chile.
    Diagn Microbiol Infect Dis. 2026;116:117451.
    PubMed         Abstract available
    
    

    
    Discov Oncol

34. ZHANG T, Zhu J, Geng L, Jin Z, et al
    FABP5 confers resistance to drug-induced ROS toxicity in cervical cancer cell lines by suppressing the PPARgamma/CPT1A signaling pathway.
    Discov Oncol. 2026 May 25. doi: 10.1007/s12672-026-05268.
    PubMed         Abstract available
    
    
35. XU C, Li H, Wu Y, Yao Q, et al
    Investigation of the clinical value of artificial intelligence-derived prognostic signature in cervical cancer based on machine learning algorithms.
    Discov Oncol. 2026 May 27. doi: 10.1007/s12672-026-05182.
    PubMed         Abstract available
    
    

    
    Front Digit Health

36. NAKASI R, Wamozo C, Nsumba S, Rukundo B, et al
    Adapting DeepLabV3+ for biopsy cervical cancer lesion segmentation.
    Front Digit Health. 2026;8:1776155.
    PubMed         Abstract available
    
    

    
    Front Immunol

37. LI Z, Pang X, Wang Z, Wen J, et al
    PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report.
    Front Immunol. 2026;17:1826847.
    PubMed         Abstract available
    
    
38. ZHANG J, Wei W, Zhang Y, Wang D, et al
    Metabolic reprogramming of cholesterol biosynthesis drives macrophage-mediated immune suppression in HPV-negative cervical adenocarcinoma.
    Front Immunol. 2026;17:1808107.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

39. WEI Y, Song F, Wang W
    Expression levels of serum SCC, HE4, and TSGF in cervical cancer patients and their correlation with recurrence: a retrospective study.
    Front Med (Lausanne). 2026;13:1813161.
    PubMed         Abstract available
    
    
40. VAJDA G, Loczi L, Vida B, Merkely P, et al
    Systemic inflammatory ratios and their added value to cytology in cervical cancer detection: a multicenter study.
    Front Med (Lausanne). 2026;13:1802477.
    PubMed         Abstract available
    
    

    
    Front Oncol

41. YAN T, Ma Q, Shi H, Qi D, et al
    Disease burden of cervical cancer in China from 1990 to 2023 and prediction of future trends.
    Front Oncol. 2026;16:1802330.
    PubMed         Abstract available
    
    
42. CHEN H, She C, Wang Z, Huang X, et al
    A ferroptosis-related lncRNAs risk score model identifies LINC02178 as a potential regulator of ferroptosis sensitivity in cervical cancer.
    Front Oncol. 2026;16:1807953.
    PubMed         Abstract available
    
    

    
    Gynecol Pelvic Med

43. MOORTHY A, Le NA, Issac A, Willmott L, et al
    Brachytherapy use in cervical cancer: a narrative review.
    Gynecol Pelvic Med. 2026;9:8.
    PubMed         Abstract available
    
    

    
    Healthcare (Basel)

44. SONGUR DAGLI S, Altun M
    Acceptability of HPV Self-Sampling for Cervical Cancer Screening Among Previously Screened Women in Turkiye: A Cross-Sectional Study.
    Healthcare (Basel). 2026;14:1312.
    PubMed         Abstract available
    
    

    
    Hum Cell

45. LIU J, Jiao Y, Wang J, Cui X, et al
    miR-141-5p positively regulates ACVRL1 expression to promote cervical cancer progression.
    Hum Cell. 2026;39:81.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

46. XUE L, Li X, Guo X, Xing H, et al
    Clinical research progress and challenges of vaccine for human papillomavirus-associated cancers.
    Hum Vaccin Immunother. 2026;22:2676391.
    PubMed         Abstract available
    
    

    
    Immunotherapy

47. PATRA S, Shand H, Ghorai S
    Beyond conventional therapies: immunotherapeutic strategies targeting HPV-associated cervical cancer.
    Immunotherapy. 2026 May 27:1-21. doi: 10.1080/1750743X.2026.2679883.
    PubMed         Abstract available
    
    

    
    Infect Agent Cancer

48. LYU Q, Zhao J, Chen Y, Xiong J, et al
    Molecular characterization of HPV integrations in high-risk HPV-positive women and development of a prognostic signature based on integration-associated genes for cervical cancer.
    Infect Agent Cancer. 2026 May 27. doi: 10.1186/s13027-026-00766.
    PubMed         Abstract available
    
    

    
    Int J Biol Macromol

49. SACHIT BA, Dass S, Rajan RS, Tye GJ, et al
    Development and characterization of novel T-cell receptor-like antibodies targeting human papillomavirus type 16 oncoprotein peptides for early cervical cancer detection using experimental and computational approaches.
    Int J Biol Macromol. 2026 May 27:152755. doi: 10.1016/j.ijbiomac.2026.152755.
    PubMed         Abstract available
    
    

    
    Int J Environ Res Public Health

50. MUSHASHA MP, Modiba LM
    Strategies to Raise Awareness About Screening and Vaccination for the Human Papillomavirus Among Women in Limpopo Province, South Africa.
    Int J Environ Res Public Health. 2026;23:657.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

51. RUSSELL JC, Amin S, Kohler RE, Kelly H, et al
    Understanding barriers to cervical cancer screening in Botswana: Insights from a cross-sectional study.
    Int J Gynaecol Obstet. 2026 May 26. doi: 10.1002/ijgo.71089.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

52. TJOKROPRAWIRO BA
    TeleDoIVA: expanding cervical cancer screening across Indonesia's Archipelago through smartphone-based teleconsultation.
    Int J Gynecol Cancer. 2026 Apr 25:104723. doi: 10.1016/j.ijgc.2026.104723.
    PubMed        
    
    

    
    Int J Mol Sci

53. JABLONSKA IA, Golawski M, Scieglinska D, Kacorzyk U, et al
    Prognostic Value of Pretreatment Circulating Tumor HPV DNA Load in HPV-Associated Cancers: A Systematic Review and Meta-Analysis.
    Int J Mol Sci. 2026;27:4263.
    PubMed         Abstract available
    
    
54. PAWLIK P, Kurzawinska G, Ozarowski M, Karpinski TM, et al
    Genetic Variations in the Fibronectin 1 Gene (FN1) and Risk of Female Reproductive Cancers-A Preliminary Study.
    Int J Mol Sci. 2026;27:4302.
    PubMed         Abstract available
    
    
55. WANG L, Ouyang Y, Zhao Q, Wang T, et al
    The Mechanism of Mg(2+)-Mediated Inhibition of Cervical Cancer by Inducing a Senescence-like State via the ATM/CHK2/p21 Signaling Pathway.
    Int J Mol Sci. 2026;27:4397.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

56. MAYADEV J, Deng W, Kim H, Xiao Y, et al
    Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2026 May 24:S0360-3016(26)00706.
    PubMed         Abstract available
    
    

    
    Int J Womens Health

57. ZHANG Y, Wu Y, Yuan J, Yang J, et al
    A Longitudinal Qualitative Study on the Perioperative Symptom-Demand Journey Map of Patients with Cervical Cancer.
    Int J Womens Health. 2026;18:603381.
    PubMed         Abstract available
    
    

    
    Integr Biol (Camb)

58. ZHANG H, Chen X, Wang B, Li L, et al
    Trim45 promotes the occurrence and development of cervical cancer by inhibiting the cGAS/STING signaling pathway.
    Integr Biol (Camb). 2026;18:zyag009.
    PubMed         Abstract available
    
    

    
    J Biomater Sci Polym Ed

59. M TMS, S P, Selvasudha N, Sivadas S, et al
    Plumbagin-PLA- chitosan nanoformulation ameliorates inflammation in cervical cancer (SiHa) cells by enhancing bioavailability and targeted drug delivery.
    J Biomater Sci Polym Ed. 2026 May 23:1-26. doi: 10.1080/09205063.2026.2676164.
    PubMed         Abstract available
    
    

    
    J Biophotonics

60. MAKIN J, Elishaev E, Durbin SM, Makin RA, et al
    Diagnostic Accuracy of Entropy Based Image Analysis of Cervical Precancerous Cells.
    J Biophotonics. 2026;19:e70294.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

61. MA J, Wang G, Wang W, Yang H, et al
    Extended-field intensity-modulated radiation therapy and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic or common iliac lymph nodes: a multicenter prospective cohort study.
    J Gynecol Oncol. 2026 May 26. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    
62. HWANG JH, Kim H
    Comparison of clinical outcomes between early and delayed diagnosis of cervical cancer following abnormal Pap smear results: a population-based cohort study using National Health Insurance data in South Korea.
    J Gynecol Oncol. 2026 May 26. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    
63. YAMAMOTO R, Asano H, Hatanaka KC, Shinomiya Y, et al
    Feasibility study of photoimmunotherapy combination with ASP-1929 for vulvar, vaginal, and cervical cancer.
    J Gynecol Oncol. 2026 May 21. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    
64. HU Y, Chen S, Cheng H, Han Y, et al
    Chemotherapy plus camrelizumab for fertility preservation (NACI-F) in FIGO stage IB1 cervical cancer: a multicenter, single-arm, phase 2 trial.
    J Gynecol Oncol. 2026 Apr 29. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    
65. ZHANG H, Zhou H, Li M, Mutailipu T, et al
    Comparison of mRNA-based and next-generation sequencing HPV assays in a population-based cervical cancer screening program in China.
    J Gynecol Oncol. 2026 May 18. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    
66. VANICHBUNCHA T, Leetanaporn K, Hanprasertpong J
    Impact of the diagnosis-surgery interval on survival outcomes and development of a nomogram for predicting survival in early-stage cervical cancer: a Surveillance, Epidemiology, and End Results database analysis.
    J Gynecol Oncol. 2026 May 14. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    

    
    J Health Popul Nutr

67. WOLDEAREGAY HG, Abebe GG, Weldemariam S, Tesfay FG, et al
    Cervical cancer screening among HIV-positive women in conflict-affected and resource limited settings: the case of Tigray region, Ethiopia.
    J Health Popul Nutr. 2026 May 23. doi: 10.1186/s41043-026-01331.
    PubMed         Abstract available
    
    

    
    J Med Screen

68. ANDERSSON H, Nordqvist Kleppe S, Edvardsson H, Elfstrom KM, et al
    Quality indicators for cervical screening in Sweden.
    J Med Screen. 2026;33:84-93.
    PubMed         Abstract available
    
    
69. MUNJAL V, Schupack KM, Miller NE, Boswell CL, et al
    Retrospective analysis of clinician and patient factors associated with unsatisfactory Pap tests.
    J Med Screen. 2026;33:94-99.
    PubMed         Abstract available
    
    
70. SMIT F, Braggion A, Cullati S, Chiolero A, et al
    Cancer screening after the age of 75: Nationwide population-based trends.
    J Med Screen. 2026;33:122-126.
    PubMed         Abstract available
    
    

    
    J Minim Invasive Gynecol

71. ILGEN O, Karatasli V
    RETROPERITONEAL SENTINEL LYMPH NODE DISSECTION USING VNOTES IN EARLY-STAGE CERVICAL CANCER: A CASE REPORT.
    J Minim Invasive Gynecol. 2026 May 21:S1553-4650(26)00283.
    PubMed         Abstract available
    
    

    
    J Virol

72. FARRUKH S, Kavcic N, Canarutto G, Piazza S, et al
    Rethinking residual p53 function in HPV-positive cervical cancer cells.
    J Virol. 2026 May 27:e0047925. doi: 10.1128/jvi.00479.
    PubMed         Abstract available
    
    

    
    Lasers Med Sci

73. LIU Y, Wu R, Li C, Li R, et al
    Systematic photodynamic therapy for concurrent cervical-vaginal high-grade squamous intraepithelial lesion: a series of eight cases.
    Lasers Med Sci. 2026;41:102.
    PubMed         Abstract available
    
    

    
    Oncol Rev

74. TULIMILLI SV, Karnik M, Cockroft S, Bettadapura ADS, et al
    Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.
    Oncol Rev. 2026;20:1760156.
    PubMed         Abstract available
    
    

    
    Pathogens

75. MISAWA Y, Mizuno S, Honda S, Shinohara R, et al
    Koilocytosis in LSIL Cytology Has Limited Predictive Value for CIN2+ in HPV-Positive Women: Implications for Risk-Based Cytology Triage.
    Pathogens. 2026;15:537.
    PubMed         Abstract available
    
    
76. BONIFACIO-VELEZ DE VILLA E, Aguilar-Luis MA, Silva-Caso W, Becerra-Goicochea L, et al
    Genetic Variability and Conserved T-Cell Epitope Prediction of the HPV16 E1 Protein in Cervix Samples from Peru.
    Pathogens. 2026;15:526.
    PubMed         Abstract available
    
    

    
    PeerJ

77. LI P, Shao Y, Wang J, Lin R, et al
    Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression.
    PeerJ. 2026;14:e21255.
    PubMed         Abstract available
    
    

    
    Pharmaceuticals (Basel)

78. ABASI X, Liang D, Rezhake R, Tuerxun G, et al
    Mechanism of Xiao-ai-fei Honey Ointment, a Traditional Uyghur Multi-Ingredient Medicinal Preparation, Against Cervical Cancer Based on Network Pharmacology and In Vitro Evaluation of Anti-Cancer Activity.
    Pharmaceuticals (Basel). 2026;19:686.
    PubMed         Abstract available
    
    

    
    Pharmacoecon Open

79. ZHANG Z, Bussmann H, Vong S, Kol H, et al
    A Micro-costing Study of Community-Based Primary HPV Self-Sampling and Triage Test for Cervical Cancer Screening in Rural Cambodia.
    Pharmacoecon Open. 2026 May 26. doi: 10.1007/s41669-026-00659.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

80. CHARNALIA M, Ranjan N, Spampinato S, Nout R, et al
    Cumulative gastrointestinal adverse events in EMBRACE-I: comparative evaluation of CTCAE vs. MOSES methods in predicting the impact of incident vs. persistent adverse events on quality of life.
    Radiother Oncol. 2026;219:111489.
    PubMed         Abstract available
    
    

    
    Sci Rep

81. BADAWY N, Alwadaany B, Safar H, Alshammaa M, et al
    Knowledge and attitudes regarding cervical cancer among adult Kuwaiti women: A cross-sectional study.
    Sci Rep. 2026 May 25. doi: 10.1038/s41598-026-53363.
    PubMed         Abstract available
    
    

    
    Stud Health Technol Inform

82. GOVARTHAN PK, Agastinose Ronickom JF, Swaminathan R
    Identification of Cervical Cancer Biomarkers Using Gene Co-Expression Networks and Machine Learning Methods.
    Stud Health Technol Inform. 2026;336:398-402.
    PubMed         Abstract available
    
    

    
    Transl Cancer Res

83. PAN H, Bao L, Shi W, Wan J, et al
    RNF112 mediates immunosuppression to inhibit the proliferation of cervical cancer by Foxm1.
    Transl Cancer Res. 2026;15:317.
    PubMed         Abstract available
    
    
84. GIANNECCHINI GV, Filgueiras ABT, de Andrade DAP, de Melo AC, et al
    Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?
    Transl Cancer Res. 2026;15:350.
    PubMed        
    
    
85. CAO L, Zhang C
    A novel programmed-cell-death-related prognostic risk model for cervical cancer based on mitochondrial genes.
    Transl Cancer Res. 2026;15:271.
    PubMed         Abstract available
    
    
86. WESSEL L, Arians N
    Postoperative proton therapy in uterine and cervical cancer: promising evidence but remaining questions.
    Transl Cancer Res. 2026;15:346.
    PubMed        
    
    

    
    Trop Doct

87. RATHOD G, Parmar P
    HPV self-sampling in low-resource settings: An overlooked opportunity for cervical cancer screening.
    Trop Doct. 2026 May 24:494755261454018. doi: 10.1177/00494755261454018.
    PubMed         Abstract available
    
    

    
    Ultrasound Obstet Gynecol

88. FRUHAUF F, Fischerova D, Moro F, Kocian R, et al
    Prospective comparison of diagnostic accuracy of ultrasound, PET/CT and DW-MRI for preoperative assessment of pelvic lymph nodes in cervical cancer patients: results of the CANNES trial.
    Ultrasound Obstet Gynecol. 2026 May 24. doi: 10.1002/uog.70241.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum